CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-180313 | Healthcare
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Congestive Heart Failure Treatment Device Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET
7.1 GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Boston Scientific Corporation
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Medtronic PLC
16.3 Abiomed, Inc.
16.4 HeartWare International, Inc.
16.5 Jarvik Heart, Inc.
16.6 LivaNova PLC
16.7 ReliantHeart Inc.
16.8 Biotronik SE & Co., KG
16.9 St. Jude Medical
16.10 Berlin Heart GmbH
16.11 Teleflex, Inc.
16.12 MicroMed Cardiovascular Inc.
16.13 Thoratec
16.14 World Heart Corporation
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By Product TypeVentricular Assist Devices (VADs)
 o Left Ventricular Assist Device (LVAD)
 o Right Ventricular Assist Device (RVAD)
 o Biventricular Assist Device (BIVAD)
Implantable Cardioverter Defibrillators (ICD)
 o Subcutaneous ICD
 o Transvenous ICD
Pacemakers
 o External
 o Implantable
Cardiac Resynchronization Therapy
 o Cardiac Resynchronization Therapy-Pacemakers (CRT-P)
 o Cardiac Resynchronization Therapy-Defibrillators (CRT-D)
Counter Pulsation Devices
By End User
Hospitals
Specialized Cardiovascular Disease Treatment Centers
Ambulatory Surgical Centers
Companies
Boston Scientific Corporation
Medtronic PLC
Abiomed, Inc.
HeartWare International, Inc.
Jarvik Heart, Inc.
LivaNova PLC
ReliantHeart Inc.
Biotronik SE & Co., KG
St. Jude Medical
Berlin Heart GmbH
Teleflex, Inc.
MicroMed Cardiovascular Inc.
Thoratec
World Heart Corporation
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.